IE39595B1 - 7 -hydroxyiminoacylamidocephalosporins - Google Patents

7 -hydroxyiminoacylamidocephalosporins

Info

Publication number
IE39595B1
IE39595B1 IE1436/74A IE143674A IE39595B1 IE 39595 B1 IE39595 B1 IE 39595B1 IE 1436/74 A IE1436/74 A IE 1436/74A IE 143674 A IE143674 A IE 143674A IE 39595 B1 IE39595 B1 IE 39595B1
Authority
IE
Ireland
Prior art keywords
july
hydroxyiminoacylamidocephalosporins
gb1472534a
brn
bromosuccinimide
Prior art date
Application number
IE1436/74A
Other languages
English (en)
Other versions
IE39595L (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IE39595L publication Critical patent/IE39595L/xx
Publication of IE39595B1 publication Critical patent/IE39595B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
IE1436/74A 1973-07-06 1974-07-05 7 -hydroxyiminoacylamidocephalosporins IE39595B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3227373A GB1472534A (en) 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins

Publications (2)

Publication Number Publication Date
IE39595L IE39595L (en) 1975-01-06
IE39595B1 true IE39595B1 (en) 1978-11-22

Family

ID=10336049

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1436/74A IE39595B1 (en) 1973-07-06 1974-07-05 7 -hydroxyiminoacylamidocephalosporins

Country Status (16)

Country Link
US (1) US4007174A (enExample)
JP (1) JPS5069093A (enExample)
AT (1) AT335061B (enExample)
BE (1) BE817304A (enExample)
CA (1) CA1055016A (enExample)
CH (1) CH615436A5 (enExample)
DE (1) DE2432415A1 (enExample)
DK (1) DK360874A (enExample)
ES (1) ES428015A1 (enExample)
FR (1) FR2235696B1 (enExample)
GB (1) GB1472534A (enExample)
IE (1) IE39595B1 (enExample)
LU (1) LU70477A1 (enExample)
NL (1) NL7409179A (enExample)
SE (1) SE7408892L (enExample)
ZA (1) ZA744349B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648415A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE311519B (enExample) * 1962-12-14 1969-06-16 Astra Ab
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) * 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics

Also Published As

Publication number Publication date
FR2235696A1 (enExample) 1975-01-31
GB1472534A (en) 1977-05-04
CH615436A5 (en) 1980-01-31
DK360874A (enExample) 1975-03-03
BE817304A (fr) 1975-01-06
AU7072374A (en) 1976-01-08
JPS5069093A (enExample) 1975-06-09
CA1055016A (en) 1979-05-22
FR2235696B1 (enExample) 1976-12-24
AT335061B (de) 1977-02-25
DE2432415A1 (de) 1975-01-30
ZA744349B (en) 1975-07-30
IE39595L (en) 1975-01-06
SE7408892L (enExample) 1975-01-07
ATA556074A (de) 1976-06-15
ES428015A1 (es) 1976-07-16
US4007174A (en) 1977-02-08
LU70477A1 (enExample) 1976-05-31
NL7409179A (nl) 1975-01-08

Similar Documents

Publication Publication Date Title
IE39595L (en) 7ß-HYDROXYIMINO ACYLAMIDOCEPHALOSPORINS
IE35894B1 (en) A substituted glutaronitrile as an antifungal agent
GB1373463A (en) 4-tetrazol-5-yl- butyltripenhylphosphonium bromide
GB1297387A (enExample)
GB1191808A (en) Preparation of Streptozotocin
GB1445845A (en) Halopenam and halcepham compounds and the preparation thereof
GB1292737A (en) Haloepoxides
GB1425409A (en) Radiation-sensitive polymers and their use
GB1448311A (en) Process for preparing hexahydrothieno-3,4-d-imidazole-2,4- diones
IE34609L (en) Therapeutic substituted thiazolidinedione
CA978525A (en) Derivatives of 1,2-dihydroquinobenzoxa(or thia) zepine-3-one, oximes
FR2311798A1 (fr) Composes organiques d'etain et leur application a la preparation de chlorure de polyvinyle cellulaire
GB1173680A (en) Heterocyclic Isocyanates
GB1435243A (en) Ketimine derivatives and process for their production
GB1409993A (en) Antitussive
GB1219176A (en) Antihypertensive compositions and their preparation
Kirilenko et al. Glass formation and chemical compounds in the systems(Si, Ge)-(S, Se)-(Br, I)
DUBROVSKA et al. Development of exact solutions of nonlinear differential equations of plane theory of elasticity with the aid of group theory(Exact solutions of elasticity theory nonlinear differential equations by Lie group theory methods)
CA810669A (en) 3,3'-ethylenebis(tetrahydro-4,6-dimethyl-2h-1,3,5-thiadiazine-2-thione)
FR2330154A2 (fr) Guide d'ondes mixte, semi-rigide, et procede de fabrication
IE34189B1 (en) A process for the preparation of trichloromethane thiosulphenyl chloride
GB1371693A (en) 4,6-dihydro-1,3-dimethyl-4-ethyl-8-phenylpyrazolo-4,3-e-1,4- diazepin-5-1h-one and compositions containing the same
USD218478S (en) Si.idk compass
Gillespie et al. The+ ⅓ oxidation state of mercury
AU462620B2 (en) Novel derivatives of 2,3-dihydroxypropyl-n-(7 or 8-chloro-4-quinolinyl) anthranilate